Polianta Ltd’s Tandem Diabetes Care TNDM Stock Holding History

Polianta Ltd’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,700	Closed	-$1.22M	–	96
2020 Q4	$1.22M	Buy	12,700 +1,300	+11%	+$134K	0.67%	42
2020 Q3	$1.29M	Buy	+11,400	New	+$1.2M	0.76%	10
2019 Q3	–	Sell	-16,600	Closed	-$1.07M	–	100
2019 Q2	$1.07M	Buy	+16,600	New	+$1.07M	0.46%	59

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Polianta Ltd's TNDM Position: Q1 2021 in Review

Polianta Ltd sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 12,700 shares — an estimated $1.22M sold.

Polianta Ltd first reported a position in TNDM in Q2 2019 and held it in 3 quarters. The position peaked at $1.29M in Q3 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

Polianta Ltd reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
Polianta Ltd sold 12,700 Tandem Diabetes Care shares in Q1 2021, an estimated $1.22M.
Polianta Ltd first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 3 quarters.
Polianta Ltd's Tandem Diabetes Care position peaked at $1.29M in Q3 2020.
290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Polianta Ltd's 13F filing for Q1 2021, filed 14 Apr 2021.